OpenAI-backed drug discovery startup Chai Discovery introduces new AI model Chai-1

Artificial Intelligence is making rapid strides in various fields. ChatGPT-maker OpenAI and venture capital firm Thrive Capital recently announced their support for Chai Discovery, a biology startup founded by former OpenAI and Meta researchers. Recently, the AI startup raised close to $30 million to develop AI models for drug discovery.

On September 9, the startup introduced Chai-1, an advanced AI model that can predict the structure of molecules, essential for drug discovery. The company has said that the model can be used for free through a web interface. Chai Discovery is also sharing the model’s code and tools for non-commercial uses so developers can build on it for research and development.